ALDX
#3968
Aldeyra Therapeutics, Inc. - Common Stock
1.4 7 USD
-0.01%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
-1.34%
Changement Mensuel
-5.16%
Evolution sur 6 mois
-73.32%
Changement Annuel
-74.17%
Clôture Précédente
1.4 9
Open
1.4 6
Low
1.4 6
High
1.4 8
Volume
46
Financials
- Market Capitalization 88.68 M
- Employee 6
- Founded 2004
- CEO Todd C. Brady M.D., Ph.D.
- Website www.aldeyra.com
- Headquarter Delaware, United States
- FIGI BBG0029H8ZF6
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-5.61
ratio cours/chiffre d'affaires
—
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 3957 |  VRCA Verrica Pharmaceuticals Inc. - Common Stock | 5.36 USD | +2.29% | +10.52% | +2.68% | -10.96% | 92.08 M USD | ||
| 3966 |  ACRV Acrivon Therapeutics, Inc. - Common Stock | 2.09 USD | +0.97% | -0.48% | +37.50% | +57.14% | 89.56 M USD | ||
| 3971 |  ICCC ImmuCell Corporation - Common Stock | 9.89 USD | -0.30% | -1.30% | -12.71% | +51.69% | 89.82 M USD | ||
| 3973 |  FBIO Fortress Biotech, Inc. - Common Stock | 2.69 USD | +0.37% | -3.93% | -7.24% | -11.51% | 89.71 M USD |